Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome - PubMed (original) (raw)
Multicenter Study
. 2022 Mar;71(3):544-552.
doi: 10.1136/gutjnl-2021-325989. Epub 2022 Jan 26.
Qin Liu # 1 2 3 4, Joyce Wing Yan Mak # 1 2 3, Qi Su # 1 2 3 4, Yun Kit Yeoh 1 4 5, Susanna So Shan Ng 2, Fen Zhang 1 2 3 4, Amy Y L Li 1 2 3, Wenqi Lu 1 2 3 4, David Shu-Cheong Hui 6, Paul Ks Chan 1 5, Francis K L Chan 1 2 3 4, Siew C Ng 7 2 3 4
Affiliations
- PMID: 35082169
- DOI: 10.1136/gutjnl-2021-325989
Multicenter Study
Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome
Qin Liu et al. Gut. 2022 Mar.
Abstract
Background: Long-term complications after COVID-19 are common, but the potential cause for persistent symptoms after viral clearance remains unclear.
Objective: To investigate whether gut microbiome composition is linked to post-acute COVID-19 syndrome (PACS), defined as at least one persistent symptom 4 weeks after clearance of the SARS-CoV-2 virus.
Methods: We conducted a prospective study of 106 patients with a spectrum of COVID-19 severity followed up from admission to 6 months and 68 non-COVID-19 controls. We analysed serial faecal microbiome of 258 samples using shotgun metagenomic sequencing, and correlated the results with persistent symptoms at 6 months.
Results: At 6 months, 76% of patients had PACS and the most common symptoms were fatigue, poor memory and hair loss. Gut microbiota composition at admission was associated with occurrence of PACS. Patients without PACS showed recovered gut microbiome profile at 6 months comparable to that of non-COVID-19 controls. Gut microbiome of patients with PACS were characterised by higher levels of Ruminococcus gnavus, Bacteroides vulgatus and lower levels of Faecalibacterium prausnitzii. Persistent respiratory symptoms were correlated with opportunistic gut pathogens, and neuropsychiatric symptoms and fatigue were correlated with nosocomial gut pathogens, including Clostridium innocuum and Actinomyces naeslundii (all p<0.05). Butyrate-producing bacteria, including Bifidobacterium pseudocatenulatum and Faecalibacterium prausnitzii showed the largest inverse correlations with PACS at 6 months.
Conclusion: These findings provided observational evidence of compositional alterations of gut microbiome in patients with long-term complications of COVID-19. Further studies should investigate whether microbiota modulation can facilitate timely recovery from post-acute COVID-19 syndrome.
Keywords: COVID-19; intestinal microbiology.
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Comment in
- Inflammation-associated gut microbiome in postacute sequelae of SARS-CoV-2 points towards new therapeutic targets.
Carneiro VL, Littlefield KM, Watson R, Palmer BE, Lozupone C. Carneiro VL, et al. Gut. 2024 Jan 5;73(2):376-378. doi: 10.1136/gutjnl-2022-328757. Gut. 2024. PMID: 36717218 Free PMC article. No abstract available.
Similar articles
- Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19.
Zuo T, Liu Q, Zhang F, Lui GC, Tso EY, Yeoh YK, Chen Z, Boon SS, Chan FK, Chan PK, Ng SC. Zuo T, et al. Gut. 2021 Feb;70(2):276-284. doi: 10.1136/gutjnl-2020-322294. Epub 2020 Jul 20. Gut. 2021. PMID: 32690600 Free PMC article. - Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.
Zuo T, Zhang F, Lui GCY, Yeoh YK, Li AYL, Zhan H, Wan Y, Chung ACK, Cheung CP, Chen N, Lai CKC, Chen Z, Tso EYK, Fung KSC, Chan V, Ling L, Joynt G, Hui DSC, Chan FKL, Chan PKS, Ng SC. Zuo T, et al. Gastroenterology. 2020 Sep;159(3):944-955.e8. doi: 10.1053/j.gastro.2020.05.048. Epub 2020 May 20. Gastroenterology. 2020. PMID: 32442562 Free PMC article. - The Relationship Between Pediatric Gut Microbiota and SARS-CoV-2 Infection.
Romani L, Del Chierico F, Macari G, Pane S, Ristori MV, Guarrasi V, Gardini S, Pascucci GR, Cotugno N, Perno CF, Rossi P, Villani A, Bernardi S, Campana A, Palma P, Putignani L; CACTUS Study Team. Romani L, et al. Front Cell Infect Microbiol. 2022 Jul 8;12:908492. doi: 10.3389/fcimb.2022.908492. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35873161 Free PMC article. - Profiles of gut microbiota associated with clinical outcomes in patients with different stages of SARS-CoV-2 infection.
Krasaewes K, Chaiwarith R, Chattipakorn N, Chattipakorn SC. Krasaewes K, et al. Life Sci. 2023 Nov 1;332:122136. doi: 10.1016/j.lfs.2023.122136. Epub 2023 Oct 1. Life Sci. 2023. PMID: 37783267 Review. - Dynamics of the Microbiota and Its Relationship with Post-COVID-19 Syndrome.
Moreno-Corona NC, López-Ortega O, Pérez-Martínez CA, Martínez-Castillo M, De Jesús-González LA, León-Reyes G, León-Juárez M. Moreno-Corona NC, et al. Int J Mol Sci. 2023 Oct 1;24(19):14822. doi: 10.3390/ijms241914822. Int J Mol Sci. 2023. PMID: 37834270 Free PMC article. Review.
Cited by
- Clinical and Immunologic Effects of Paraprobiotics in Long-COVID Patients: A Pilot Study.
Docampo MJ, Batruch M, Oldrati P, Berenjeno-Correa E, Hilty M, Leventhal G, Lutterotti A, Martin R, Sospedra M. Docampo MJ, et al. Neurol Neuroimmunol Neuroinflamm. 2024 Sep;11(5):e200296. doi: 10.1212/NXI.0000000000200296. Epub 2024 Aug 6. Neurol Neuroimmunol Neuroinflamm. 2024. PMID: 39106427 Free PMC article. - Gut as an Alternative Entry Route for SARS-CoV-2: Current Evidence and Uncertainties of Productive Enteric Infection in COVID-19.
Clerbaux LA, Mayasich SA, Muñoz A, Soares H, Petrillo M, Albertini MC, Lanthier N, Grenga L, Amorim MJ. Clerbaux LA, et al. J Clin Med. 2022 Sep 26;11(19):5691. doi: 10.3390/jcm11195691. J Clin Med. 2022. PMID: 36233559 Free PMC article. Review. - Antibiotics and probiotics impact gut antimicrobial resistance gene reservoir in COVID-19 patients.
Su Q, Liu Q, Zhang L, Xu Z, Liu C, Lu W, Ching JY, Li A, Mak JWY, Lui GCY, Ng SSS, Chow KM, Hui DS, Chan PK, Chan FKL, Ng SC. Su Q, et al. Gut Microbes. 2022 Jan-Dec;14(1):2128603. doi: 10.1080/19490976.2022.2128603. Gut Microbes. 2022. PMID: 36201636 Free PMC article. - Modulated Gut Microbiota for Potential COVID-19 Prevention and Treatment.
Zhao S, Feng P, Meng W, Jin W, Li X, Li X. Zhao S, et al. Front Med (Lausanne). 2022 Mar 3;9:811176. doi: 10.3389/fmed.2022.811176. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35308540 Free PMC article. Review. - Association between Gut Microbiota and SARS-CoV-2 Infection and Vaccine Immunogenicity.
Ng HY, Leung WK, Cheung KS. Ng HY, et al. Microorganisms. 2023 Feb 10;11(2):452. doi: 10.3390/microorganisms11020452. Microorganisms. 2023. PMID: 36838417 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous